Ms. Mundkur has almost three decades of experience in the pharmaceutical industry. Most recently, she served as CEO and Non-voting Chairman of the Board of Directors of Impopharma Inc., a developer of complex formulations focused on inhalation pharmaceutical products. In addition, she has held the position of President & CEO for North America for Sandoz Inc. Previously, she was the CEO of Barr Laboratories, Inc. Currently, she also serves on the Board of Directors of MannKind Corporation in the U.S.
|Appointed||April 1, 2019|
|Committee Membership||Member of the Audit Committee, Nomination & Remuneration Committee and Risk Management Committee|